FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study

WASHINGTON (AP) — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using mind-altering substances to treat serious mental health conditions. Drugmaker...

FDA won't approve the psychedelic drug MDMA for PTSD, calling for more research on its safety and effectiveness

WASHINGTON (AP) — FDA won't approve the psychedelic drug MDMA for PTSD, calling for more research on its safety and effectiveness.